AMH, Inhibin A, FSH, and Ovarian Cancer Risk in the JANUS Serum Bank

Nathaniel Rothman

Studies in the Janus Cohort

Ovary

Pathology

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Ovary

Hematology and hematologic malignancies Pathology

Thomas A Sellers

Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)

Ovary

Pathology

Dipanjan Chowdhury

Molecular mechanism and relevance of microRNAs in DSB repair pathway choice

Ovary Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology Radiation Oncology

Brad Nelson

Mechanisms of Protective Immunity in Ovarian Cancer

Ovary

Neil Johnson

Identifying BRCA1 protein variants that provide resistance to therapy

Ovary Breast

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Trachea, bronchus and lung Stomach Prostate Pancreas Ovary Oesophagus Non-Hodgkin lymphoma Nasopharynx Multiple myeloma and immunoproliferative diseases Liver and intrahepatic bile ducts Leukaemia Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast Brain, nervous system Bladder

Thomas Spies

Stimulation of Tumorigenesis by NKG2D

Ovary Breast

Pathology

The Role of microRNA, mir-30d, in the Initiation and Progression of Cancer

Ovary Breast